OpenAlex
PricingAboutJobs
Log inGet started
Work

PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All

HTML

Year: 2019
Type: article
Source: Neurochemical Research
DOI: 10.1007/s11064-019-02809-1
Authors: Alejandro Lloret, M. Flint Beal
Institution: Weill Cornell Medicine
Language: English

Topic: Sirtuins and Resveratrol in Medicine
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Keywords: Huntington's disease, NAD+, nicotinamide riboside, sirtuins, SIRT1, PGC-1α, peroxisome proliferator-activated receptors, SIRT3, PARP inhibitors, mitochondrial function, reactive oxygen species, bioenergetics, neuroprotection, neurodegenerative diseases
SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Neurological Disorders and Stroke
Award: NAD, PGC-1alpha and SIRT3 as Therapeutics Targets for Huntington's Disease
OpenAlex ID: W2944287087
FWCI: 3.184
Cites: 169
Cited by: 57
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security